Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDCA and Low Dose Methylprednisolone in PBC with AIH Features
NCT04617561Phase 4Unknown
- Sponsor
- West China Hospital of Sichuan University
- Start
- Nov 2020
- Primary completion
- Nov 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of methylprednisolone in primary biliary cholangitis (PBC), sponsored by West China Hospital of Sichuan University. Status: unknown.
02
Drugs
methylprednisolone
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT04617561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04617561.